- Methylpentynol
-
Methylpentynol Systematic (IUPAC) name 3-methylpent-1-yn-3-ol Clinical data Pregnancy cat. ? Legal status ? Identifiers CAS number 77-75-8 ATC code N05CM15 PubChem CID 6494 UNII B017BC5B1N Chemical data Formula C6H10O Mol. mass 98.143 g/mol (what is this?) (verify) Methylpentynol (Methylparafynol, Dormison, Atemorin) is a hypnotic/sedative with anticonvulsant effects. It was discovered by Bayer in 1928[1] and was previously used for the treatment of insomnia but has been replaced by newer drugs with better safety profiles.[2][3][4][5]
References
- ^ DE Patent 289800
- ^ Hirsh, H. L.; Orsinger, W. H. (1952). "Methylparafynol--a new type hypnotic. Preliminary report on its therapeutic efficacy and toxicity". American practitioner and digest of treatment 3 (1): 23–26. PMID 14903452.
- ^ Schaffarzick, R. W.; Brown, B. J. (1952). "The anticonvulsant activity and toxicity of methylparafynol (dormison) and some other alcohols". Science 116 (3024): 663–665. PMID 13028241.
- ^ Herz, A. (1954). "A new type of hypnotic; unsaturated tertiary carbinols; experimental studies on therapeutic use of 3-methyl-pentin-ol-3 (methylparafynol)". Arzneimittel-Forschung 4 (3): 198–199. PMID 13159700.
- ^ Weaver, L. C.; Alexander, W. M.; Abreu, B. E. (1961). "Anticonvulsant activity of compounds related to methylparafynol". Archives internationales de pharmacodynamie et de therapie 131: 116–122. PMID 13783544.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.